Skip to content

Generate Biomedicines, Inc. GENB Temporary Equity Dividends Adjustment

Temporary Equity Dividends Adjustment at other companies

Ondas, Inc.
 logo
Ondas, Inc. ONDS
$1.29M+57.8%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$1.29M+57.8%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$1.1M-16.5%
SIT
SiteOne Landscape SupplySITE
$2.6M
ServiceTitan, Inc. logo
ServiceTitan, Inc.TTAN
$0-100%
Schering-Plough logo
Schering-PloughSGP
0

Other financials

Income statement

See full
Revenue$7.2M-18.1%
Operating income-$64.1M-33.1%
Net income-$61.4M-47.4%
EPS (diluted)-$1.07+34.0%

Balance sheet

See full
Cash & equivalents$160.6M-27.2%
Total debt$65.6M
Total equity$514.8M+209%
Total assets$625.7M

Cash flow

See full
Operating cash flow-$80.4M-51.2%
CapEx$3.8M+403%
Free cash flow-$84.2M-56.1%

Valuation

See full
Market cap$1.86B
Enterprise value$1.76B

Returns & leverage

See full
Debt / equity0.1×
Current ratio9.2×

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:TemporaryEquityDividendsAdjustment.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's temporary equity dividends adjustment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's temporary equity dividends adjustment?
Generate Biomedicines, Inc. (GENB) reported temporary equity dividends adjustment of $7.75M in Q1 2026.